Repro Med Systems Inc (REPR) financial statements (2021 and earlier)

Company profile

Business Address 24 CARPENTER RD
CHESTER, NY 10918
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,8713,7393,3134,2022,5572,2271,930
Cash and cash equivalents5,8713,7393,3134,2022,5572,2271,930
Receivables3,2351,4261721,3501,6241,7451,115
Inventory, net of allowances, customer advances and progress billings2,3882,1041,3541,0401,2278191,150
Inventory2,3882,1041,3541,0401,2278191,150
Prepaid expense387247176265241246
Deposits current assets    260259257
Prepaid expense and other current assets181
Other undisclosed current assets 1,5181,764261   
Total current assets:11,8819,0336,7807,1195,9085,2954,633
Noncurrent Assets
Operating lease, right-of-use asset374
Property, plant and equipment6128599329971,161839876
Intangible assets, net (including goodwill)8076324272481814323
Intangible assets, net (excluding goodwill)8076324272481814323
Other noncurrent assets202031313174
Prepaid expense and other noncurrent assets83
Deferred tax assets, net1     
Other undisclosed noncurrent assets188    (43)(23)
Total noncurrent assets:2,0011,5121,3911,2761,373913959
TOTAL ASSETS:13,88210,5458,1708,3947,2816,2095,592
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,2641,5801,3671,085669749457
Accounts payable573453772308243247110
Accrued liabilities1,297689417499304263170
Employee-related liabilities1904221771491227350
Taxes payable20517 129 166127
Debt142     (45)
Deferred lease income 4
Deferred revenue and credits2222222222
Other undisclosed current liabilities      91
Total current liabilities:2,4061,5841,3891,108692772525
Noncurrent Liabilities
Long-term debt and lease obligation239     394
Long-term debt, excluding current maturities      394
Finance lease, liability3
Operating lease, liability237
Liabilities, other than long-term debt  105168316245316
Deferred revenue and credits22456790112
Deferred tax liabilities, net 82123249155204
Total noncurrent liabilities:239 105168316245710
Total liabilities:2,6461,5841,4941,2761,0081,0171,236
Stockholders' equity
Stockholders' equity attributable to parent11,2368,9616,6767,1186,2735,1924,357
Common stock422409406405403389389
Treasury stock, value(344)(344)(344)(247)(166)(142)(142)
Additional paid in capital6,2934,5954,1303,9683,8553,5123,512
Deferred compensation equity   (28)(56)(52)(184)
Retained earnings4,8654,3002,4853,0202,2371,484781
Total stockholders' equity:11,2368,9616,6767,1186,2735,1924,357
TOTAL LIABILITIES AND EQUITY:13,88210,5458,1708,3947,2816,2095,592

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
Revenues23,16317,35412,29412,24711,2458,6997,764
Revenue, net12,29412,24711,2458,6997,764
Cost of revenue(8,309)(6,543)(4,724)(4,644)(4,557)(3,622)(3,010)
Cost of goods and services sold(8,309)(6,543)(4,724)(4,644)(4,557)(3,389)(2,819)
Gross profit:14,85410,8107,5707,6036,6885,0774,754
Operating expenses(14,268)(9,646)(8,306)(6,422)(5,540)(4,069)(3,691)
Operating income (loss):5861,165(736)1,1811,1471,0081,062
Nonoperating income (expense)637(39)(35)(72)3(24)
Investment income, nonoperating    678
Foreign currency transaction loss, before tax(18)(21)(41)(26)(78)(0)(4)
Other nonoperating income (expense)81283(9)   
Interest and debt expense(0) (2)(3)(1)(5)(28)
Other undisclosed income from continuing operations before equity method investments, income taxes485     
Income (loss) from continuing operations before equity method investments, income taxes:6961,177(777)1,1431,0751,0061,010
Other undisclosed income from continuing operations before income taxes     528
Income (loss) from continuing operations before income taxes:6961,177(777)1,1431,0751,0101,038
Income tax expense (benefit)(132)(266)242(360)(321)(307)(312)
Net income (loss) available to common stockholders, diluted:564911(535)783753703726

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
Net income (loss):564911(535)783753703726
Comprehensive income (loss), net of tax, attributable to parent:564911(535)783753703726

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: